Handbook of Pediatric Transfusion Medicine

Handbook of Pediatric Transfusion Medicine

von: Ronald Strauss, Naomi Luban, Christopher Hillyer

Elsevier Trade Monographs, 2004

ISBN: 9780080491431 , 415 Seiten

Format: PDF, ePUB, OL

Kopierschutz: DRM

Windows PC,Mac OSX geeignet für alle DRM-fähigen eReader Apple iPad, Android Tablet PC's Apple iPod touch, iPhone und Android Smartphones Online-Lesen für: Windows PC,Mac OSX,Linux

Preis: 124,00 EUR

Mehr zum Inhalt

Handbook of Pediatric Transfusion Medicine


 

Front Cover

1

Handbook of Pediatric Transfusion Medicine

4

Copyright Page

5

Table of Contents

8

Preface

14

Acknowledgments

16

About the Editors

18

List of Contributors

20

Chapter 1. Blood Donation

22

Overview

22

Donor Recruitment

22

Autologous Donation

23

Directed Donation

24

Limited Donor Exposure

24

Blood Collection

24

Apheresis

29

Plasmapheresis

29

References

29

Chapter 2. Component Preparation and Storage

32

Introduction

32

Unique Transfusion Needs of the Neonatal and Pediatric Patient

32

Blood Donation Issues

38

Anticoagulant-Preservative Solutions

39

Individual Components for Transfusion

40

Record Keeping for Component Preparation

43

Storage of Blood and Blood Products

44

Summary

45

References

45

Chapter 3. Blood Components

48

Introduction

48

Whole Blood and Packed Red Blood Cells

48

Platelets

52

Granulocytes

54

Plasma Products

55

Cryoprecipitate

57

Ordering

57

Coagulation Factors

58

Albumin

59

Gamma-Globulins

60

References

63

Chapter 4. Red Blood Cell Antigens and Human Blood Groups

66

Introduction

66

ABO Blood Group System

66

RH Blood Group System

68

Kell Blood Group System

69

Duffy Blood Group System

70

Clinical Significance

70

Kidd Blood Group System

70

MNS Blood Group System

71

P Blood Group System

72

Lutheran Blood Group System

72

Lewis Blood Group System

73

Diego Blood Group System

74

Cartwright Blood Group System

74

Xg Blood Group System

74

Scianna Blood Group System

75

Dombrock Blood Group System

75

Colton Blood Group

76

LW Blood Group System

77

Chido-Rogers Blood Group System

77

Hh Blood Group System

77

XK Blood Group System

78

Gerbich Blood Group System

78

Cromer Blood Group System

78

Knops Blood Group System

79

Indian Blood Group System

79

Ok Blood Group System

79

RAPH Blood Group System

79

JMH Blood Group System

80

Cost Blood Group Collection

80

Er Blood Group Collection

80

Ii Blood Group Collection

80

Globoside Collection

81

Low-Prevalence Antigens

81

High-Prevalence Antigens

82

References

82

Chapter 5. Pretransfusion Compatibility Testing

84

Introduction

84

ABO(H)

84

Rh(D)

86

Other Red Cell Antigens

87

Direct Antiglobulin Test

88

Antibody Detection Test (Screen)

88

Crossmatch (XM)

90

Turnaround Times

91

Suggested Reading

92

References

82

Chapter 6. Serologic Investigation of Unexpected Antibodies

94

Introduction

94

Common Antibody Identification Methods

94

Process for Evaluation of Positive Antibody Detection Tests

98

References

104

Chapter 7. Leukoreduced Products: Prevention of Leukocyte-Related Transfusion-Associated Adverse Effects

106

Introduction

106

Rationale for Leukoreduction of Blood Components

106

Specific Indications for LR Products

106

Contraindications, Side Effects, and Hazards

109

Leukoreduction Technologies

109

Products, Standards, and Quality Control

110

Universal Leukoreduction

110

Leukoreduced Blood Products and Pediatric Transfusion Medicine

111

References

111

Chapter 8. Preparation of Blood Components to Reduce Cytomegalovirus and Other Infectious Risks

114

Introduction

114

Red Blood Cell and Platelet Components with Reduced Infectious Risks

114

Plasma Components, Derivatives, and Factors to Eliminate Pathogens

118

Nucleic Acid Targeted Inactivation Strategies

118

Summary

119

References

119

Chapter 9. Irradiated Products

122

History

122

Pathogenesis

122

Clinical Manifestations

123

Diagnosis of TA-GVHD

123

Time Course of Microchimerism

123

Groups at Risk

124

The Irradiation Process

124

Instrumentation for Irradiation

125

Components to be Irradiated

126

Storage of Red Cells and Platelets after Irradiation

127

Selection of Radiation Dose

128

Quality Assurance Measures

129

Confrming That Irradiation Occurred

129

New Methods in the Prevention of TA-GVHD

130

Treatment of TA-GVHD

131

References

131

Chapter 10. Washed and/or Volume- Reduced Blood Components

134

Introduction

134

Washed Red Blood Cells

134

Washed And Volume-Reduced Platelet Concentrates

138

References

140

Chapter 11. Technical Considerations/Mechanical Devices

142

Introduction

142

Intravenous Delivery Systems for Blood and Components

142

Exchange Transfusion in the Newborn

147

References

149

Chapter 12. Red Blood Cell Transfusions in the Neonate, Infant, Child, and Adolescent

152

Introduction

152

RBC Transfusions for Children and Adolescents

152

RBC Transfusions for Neonates and Infants

154

References

156

Chapter 13. Transfusion of the Pediatric Surgery, Trauma, and Intensive Care Unit Patient

158

Abstract

158

Age, Size, and Rate of Transfusion

158

Red Blood Cell Transfusion

160

Platelet Transfusions

161

Cryoprecipitate and Fresh Frozen Plasma

163

Hemostatic Agents in Acute Care

167

References

168

Chapter 14. Pediatric Transfusion in Developing Countries

170

Introduction

170

Special Transfusion Issues in Resource-Restricted Countries

170

Blood Collection and Processing in Developing Countries

172

Risks of Infectious Disease Transmission by Transfusion

174

Current Transfusion Practices

176

Prevention Measures to Reduce Need for Transfusion

177

References

177

Chapter 15. Exchange Transfusion in the Infant

180

Introduction

180

Rationale and Indications

180

Procedure

182

Selection of Donor Blood

183

Complications

184

References

185

Chapter 16. Granulocyte Transfusions in the Neonate and Child

188

Abstract

188

Introduction

188

Myelopoiesis

189

Neonatal Neutropenia and Dysfunction

189

Childhood Neutropenia

190

Mobilization of Donor Granulocytes

192

Therapeutic Granulocyte Transfusions in Children and Adults

194

Granulocyte Transfusion in the Neonate

198

Summary and Recommendations of Granulocyte Transfusions

199

References

200

Chapter 17. Extracorporeal Membrane Oxygenation and Cardiopulmonary Bypass

202

Introduction

202

Circuit for ECMO and CPB

202

ECMO

204

CPB

207

Summary

209

References

209

Chapter 18. Hemolytic Disease of the Newborn

212

Introduction

212

Immune-Mediated Hemolytic Disease

212

Rh Hemolytic Disease

213

ABO Hemolytic Disease

215

Hemolytic Disease Due to Other Red Cell Antibodies

216

T Activation

219

Autoimmune Hemolytic Disease

220

Red Cell Enzyme Deficiencies

220

Red Cell Membrane Defects

221

Disorders of Hemoglobin Synthesis

222

Other Causes of Hemolytic Disease in Neonates

223

Therapy

223

References

228

Chapter 19. Hemoglobinopathies

230

Introduction

230

Sickle Cell Disease

230

Thalassemias

238

References

239

Chapter 20. The Bleeding Child: Congenital and Acquired Disorders

242

Abstract

242

Introduction

242

Coagulation Overview

242

Clinical Evaluation of Bleeding Problems

243

Laboratory Evaluation

244

Specific Factor Assays

246

Inherited Coagulation Disorders

246

Acquired Hemorrhagic Disorders

259

References

262

Chapter 21. Transfusion of the Patient with Autoimmune Hemolysis

266

Introduction

266

Clinical Presentation and Laboratory Findings

266

Classification

266

Warm Autoimmune Hemolytic Anemia

267

Cold Agglutinin Syndrome

268

Mixed-Type Autoimmune Hemolytic Anemia

269

Drug-Induced Hemolytic Anemia

269

Less Common Types of Autoimmune Hemolytic Anemia

270

Transfusion Therapy in Autoimmune Hemolytic Anemia

271

References

272

Chapter 22. Platelet Transfusions in the Infant and Child

274

Introduction

274

Platelet Products and Special Preparations

274

Platelet Transfusions in Children

277

Platelet Transfusions in Neonates

280

Reactions to Platelet Transfusions

284

Potential Alternatives to Platelet Transfusions

286

References

286

Chapter 23. Bone Marrow–Derived Stem Cells

292

Introduction

292

Product Description

292

Collection and Storage

294

Special Preparation and Processing

295

Expected Response

299

Alternative HPC Sources

300

References

301

Chapter 24. Peripheral Blood Stem Cells

304

Introduction

304

Product Description

304

Collection

306

Special Preparation

308

Ordering and Administration

311

Potential Adverse Effects

312

Alternative HPC Sources

313

References

313

Chapter 25. Umbilical Cord Blood Stem Cells

316

Introduction

316

Collection, Storage, and Handling

316

Clinical Applications

318

References

320

Chapter 26. Transfusion Reactions

322

Introduction

322

Acute Hemolytic Transfusion Reactions

322

Febrile Nonhemolytic Transfusion Reactions

328

Allergic Transfusion Reactions

330

Delayed Hemolytic Transfusion Reactions

332

Special Considerations for Newborn Infants

335

References

336

Chapter 27. Noninfectious Complications of Pediatric Transfusion

338

Introduction

338

Transfusion Reactions

338

Metabolic Complications

341

Cardiac Overload

343

Alloimmunization

343

T Antigen Activation

343

Dilutional Coagulopathy

344

Complications of Iron Overload from Chronic Transfusion

344

References

346

Chapter 28. Infectious Complications

350

Introduction

350

Human Immunodeficiency Virus

350

Hepatitis

352

Human T-Cell Lymphotropic Virus (HTLV)

354

Cytomegalovirus

355

Parvovirus B19

356

Parasitic Infections

357

Creutzfeldt-Jakob Disease

358

Bacterial Infections

358

References

360

Chapter 29. Therapeutic Apheresis

364

Introduction

364

Goals of Therapeutic Apheresis

364

Indication Categories

366

Physiology and Adverse Effects

367

General Approach to Pediatric Patients Needing Therapeutic Apheresis

368

Planning Pediatric Procedures

369

Vascular Access

369

Hemodynamic Challenges

370

Procedural Modifications for Pediatric Patients

370

Summary

372

Suggested Reading

372

Chapter 30. Therapeutic Cytapheresis

374

Introduction

374

Evidence-Based Practice Guidelines

374

General Technical Considerations for Pediatrics

375

Erythrocytapheresis/Red Cell Exchange Transfusion

375

Leukapheresis

380

Plateletpheresis (Thrombocytapheresis)

382

Adverse Reactions

383

References

384

Chapter 31. Therapeutic Plasma Exchange: Rationales and Indications

386

Introduction

386

Guillain-Barré Syndrome

386

Chronic Inflammatory Demyelinating Polyneuropathy

388

Sydenham’s Chorea and PANDAS

389

Rasmussen’s Encephalitis

390

Thrombotic Thrombocytopenic Purpura

390

Hemolytic Uremic Syndrome

391

Familial Hypercholesterolemia

391

Refsum’s Disease

392

Focal Segmental Glomerulosclerosis

392

Solid Organ Transplantation

393

Other Diseases

394

Summary

395

References

395

Appendix. Transfusion Formulas

396

Approximate Blood Volumes (BV)

396

Plasma Volume (PV)

396

Red Blood Cell (RBC) Transfusion

396

Estimation of Blood Volume Exchanged

396

Partial Exchange Transfusion for Polycythemia

397

Exchange Transfusion for Anemia

397

Preparation of Blood Product with Specific Hct Using FFP

397

Platelet Transfusion

397

Coagulation

397

Massive Transfusions

398

Composition of Anticoagulants

398

Index

400